A new report from the UK finds that when it comes to treating alcohol-related ailments, middle-aged patients cost England’s National Health Service 10 times more than younger adults.
A study published yesterday in the Archives of Internal Medicine shows many prescription drugs could have a longer shelf life than assumed, in some cases much longer. But while the results could have important implications for drug companies, researchers are quick to caution consumers against applying the findings to their own medicine cabinets.
One in four Americans over age 45 take the cholesterol-lowering drugs collectively known as statins. Recently, some researchers have raised concern that these drugs could increase diabetes risk, especially among post-menopausal women or people taking high statin doses. But a large new analysis shows that the cardiovascular benefits of statins outweigh diabetes concerns, even for high-risk groups.
A growing body of research suggests a strong link between type 2 diabetes and the development of Alzheimer’s disease. Now a team of scientists from New Jersey and Northwestern Universities think they’ve figured out why.
Something in the way you move could be an early indicator of cognitive impairment. Five studies presented at an international Alzheimer’s Association conference this month show that a person’s gait becoming slower, less controlled or more variable is often a sign of concurrent problems with thinking skills such as memory, processing info or planning and carrying out activities.
A new report finds 20 percent of older adults suffer from mental health or substance abuse problems. With an aging boomer population and a serious shortage of doctors, nurses and other health workers trained in mental health care, “the burden of mental illness and substance abuse disorders in older adults in the United States borders on a crisis,” researchers say.